FIELD: medicine. SUBSTANCE: method involves administering 5-fluoruracyl to reach total dose of 3.5-5.2 g daily during 5 days and then platinum preparation is administered at a total dose of 80-100 mg immediately before exposing patient to radiation in dynamic multifractioning mode. EFFECT: enhanced effectiveness of treatment; inhibited growth of subclinical metastases.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF PATIENTS WITH LOCALLY SPREAD CANCER FORMS | 1993 |
|
RU2088288C1 |
| METHOD OF TREATING RECTAL CANCER | 2010 |
|
RU2424013C1 |
| METHOD OF TREATING ADENOGENOUS LOCALLY ADVANCED CANCER OF LOWER AMPULLARY PART OF RECTUM | 2013 |
|
RU2547999C1 |
| METHOD TO TREAT ONCOLOGICAL PATIENTS | 1993 |
|
RU2089247C1 |
| METHOD OF TREATING RECTAL CANCER | 2015 |
|
RU2586042C1 |
| METHOD OF TREATMENT OF UNRESECTABLE PANCREATICODUODENAL CANCER | 2007 |
|
RU2341308C1 |
| METHOD FOR TREATING PATIENTS POSSESSING CEREBRAL TUMOR | 1997 |
|
RU2125871C1 |
| METHOD OF COMBINATION TREATMENT OF OPERABLE NON-SMALL CELL LUNG CANCER STAGE III | 2015 |
|
RU2590866C1 |
| METHOD FOR TREATING MALIGNANT BONE TUMORS AND OSTEOLYTIC METASTASES IN BONE | 1997 |
|
RU2144398C1 |
| METHOD OF COMBINATION TREATMENT OF LOCALLY ADVANCED RECTAL CANCER | 2015 |
|
RU2599043C1 |
